18 trends tracked about this subject — the full history, oldest to newest below.
Scientists have conducted the first-ever test of prime editing to alter DNA directly inside the human body, potentially offering a cure for genetic diseases.
6 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Recent coverage examines whether new genome editors are surpassing traditional CRISPR technology.
A single CRISPR infusion achieved a sustained reduction in bad cholesterol for an entire year.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Anthropic reports its AI model Claude discovered a novel CRISPR-like enzyme system.
6 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
A genetically modified pig kidney functioned in a human body for a record nine months as a bridge to a human transplant.
Recent breakthroughs in CRISPR gene-editing technology have enabled the creation of hypoallergenic beagles, offering a new option for allergy sufferers.
Kindred Companion Sciences has used CRISPR gene-editing to create hypoallergenic beagles by removing a major allergy-causing protein.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Researchers are leveraging AlphaFold3's contact modelling to redesign gene-editing proteins for increased precision and safety in DNA base editing.
3 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
The identification of a master gene governing early human development is colliding with advancements in CRISPR precision, sparking new ethical debates.
The gene editing landscape is expanding rapidly through next-generation CRISPR tools and significant projected market growth through 2028.
CRISPR now targets 'undruggable' cancer mutations with surgical precision—could this rewrite oncology?